Glaukos Poised for $1B in Sales by 2030: Piper Sandler Predicts With Stock Upgrade
Portfolio Pulse from Vandana Singh
Piper Sandler has upgraded Glaukos Corporation (NYSE:GKOS) to Overweight from Neutral, predicting $1 billion in sales by 2030. The upgrade is based on the company's conservative 2023 guidance and the potential of its iStent Infinite and iDose products.
June 07, 2023 | 6:59 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Piper Sandler upgraded Glaukos Corporation (GKOS) to Overweight, predicting $1 billion in sales by 2030 due to conservative guidance and the potential of its iStent Infinite and iDose products.
The upgrade by Piper Sandler is based on Glaukos Corporation's conservative 2023 guidance and the potential of its iStent Infinite and iDose products. The analyst believes that the Street is underestimating the ramp of these products, which could lead to significant top-line upside potential in 2024 and 2025. This positive outlook is likely to have a short-term positive impact on GKOS stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100